Projects: 

 

 

  • Identification of market opportunity for a new generic provider 

  • Negotiating with government departments on behalf of one of the
    most respected OTC suppliers

  • Positioning a PBS listed medication to achieve a further
    indication in a new therapeutic area

  • PBS listing of a novel pharmaceutical preparation for an
    entirely new treatment process

  • Preparation of PBAC submissions to remove medications
    from a Therapeutic Class

  • Seeking new indications for PBS listed medications

  • Advising on pricing implications during recent government reforms

  • Development of a UKPDS based risk engine within a complex
    Markov Model including Monte-Carlo simulations

 

Publications:

 

PUBLICATIONS/CONFERENCE PRESENTATIONS

 

  • Richard Hellmund, Matt Kirchmann, Kelly Makarounas-Kirchmann.  “Cost Effectiveness of FreeStyle Libre® Flash Glucose Monitoring System from an Australian Health Care Payer Perspective”. Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting 2016.
  • Makarounas-Kichmann K., Kirchmann M., Monin N. “Lacosamide for the Treatment of Partial Onset Seizures With or Without Secondary Generalisation: Cost-Effectiveness Analysis on Treating Patients With Lacosamide in Combination With a Non-Sodium Anti-Epileptic Medication”. Value in Health Nov. 2012 Vol 15 (7) pp.A676-677.
  • Weber C, Ademi Z, Makarounas-Kirchmann K, Stoelwinder J.(2012)  “Economic evaluation of compression therapy in venous leg ulcer randomised controlled trials: A Systematic Review” Wound Practice and Research (in press)
  • Makarounas-Kirchmann K. (2012), “ICER Thresholds in a galaxy far, far away….”, ARCS Conference, Canberra, Australian September 2012
  • Makarounas-Kirchmann K., Kirchmann M., Ademi Z., Stoelwinder J. (2012), “Predictors of successfully listing on the PBS: a 2012 update”, ISPOR, Taipei, Taiwan, September 2012
  • Makarounas-Kirchmann K., Ademi Z., Kirchmann M., (2012), “Pharmaceutical Benefits Advisory Committee Acceptability Threshold Results 2005-2011". Value in Health Nov. 2012 Vol 15 (7) pp. A622.
  • Ioannides-Demos LL, Makarounas-Kirchmann K, et al. (2010). "Cost of Myocardial Infarction to the Australian Community A Prospective, Multicentre Survey." Clinical Drug Investigation 30(8): 1-11.
  • Makarounas-Kirchmann K, Glover-Koudounas S, et al. (2009). "Results of a Meta-analysis Comparing the Tolerability of Lercanidipine and other Dihydropyridine Calcium Channel Blockers", Clinical Therapeutics 31(8): 1652-1663.
  • Makarounas-Kirchmann K and Stoelwinder J (2007). “Predicting successful listing of pharmaceuticals on the PBS”, 6th World Congress on Health Economics, iHEA. Coppenhagen, Denmark, July 2007.
  • Makarounas-Kirchmann K (2003). Pharmaceutical Pricing. Pricing Conference, HIR, Singapore.
  • Pratt NL, Beilby JJ, et al. (2001). The Costs of Uncontrolled Hypertension - A Preliminary Overview. 17th International Conference on Pharmacoepidemiology Toronto, Canada.
  • Bishop JF and Macarounas-Kirchmann K (1997). "Pharmacoeconomics of Cancer Therapies." Seminars in Oncology 24(Suppl 19): 106-111.
  • Grobler MP, Macarounas-Kirchmann K, et al. (1997). "A Industry Comment on the 1995 Revised Australian Pharmacoeconomic Guidelines." PharmacoEconomics 9(4): 353-356.
  • Nord E, Richardson J, et al. (1993). "Social Evaluation of Health Care Versus Personal Evaluation of Health States: Evidence on the Validity of Four Health State Scaling Instruments Using Norwegian and Australian Survey Data." International Journal of Health Technology

 

RESEARCH REPORTS

  • T Jackson and K Macarounas-Kirchmann (1993) Report to Dandenong Hospital on a five hospital study of intensive care bed utilisation, 1987-1990 NHMRC NCHPE, Fairfield, Victoria
  • T Jackson and K Macarounas-Kirchmann (1993) Report to Geelong Hospital on a five hospital study of an intensive care bed utilisation NHMRC NCHPE, Fairfield, Victoria
  • T Jackson and K Macarounas-Kirchmann (1993) Report to Monash Medical Centre on a five hospital study of intensive care bed utilisation, 1987-1990 NHMRC NCHPE, Fairfield, Victoria
  • T Jackson and K Macarounas-Kirchmann (1993) Report to the Austin Hospital on a five hospital study of intensive care bed utilisation, 1987-1990 NHMRC NCHPE, Fairfield, Victoria
  • Jackson T, Macarounas-Kirchmann K. (1992) Changing patterns of intensive care unit admission and length of stay in five Victorian hospitals. In: Selby-Smith C, editor. Economics and health Melbourne: Monash University/NCHPE
  • Nord E., Richardson J., Macarounas-Kirchmann K., (1993) Social Evaluation of Health Care Versus Personal Evaluation of Health States: Evidence on the Validity of Four Health State Scaling Instruments Using Norwegian and Australian Survey Data, Working Paper No.23, NHMRC NCHPE
  • Richardson J., Macarounas K., Milthorpe F., Ryan J. and Smith N., (1991) An Evaluation of the Effect of Increasing Doctor Numbers in their Geographic Distribution, Technical Report No.1, NHMRC NCHPE
  • Jackson T., Macarounas-Kirchmann K.P., (1992) "Utilisation of Intensive Care Units in Five Victorian Hospitals, FY1987-FY 1990", in C. Selby Smith, Economics and Health: Proceedings of the 14th Australian Conference of Health Economists

 

 

Contact us: 

 

t : +61 3 9787 9100

This email address is being protected from spambots. You need JavaScript enabled to view it.